CME Fortbildung

Dank der freundlichen Unterstützung des Thieme Verlags freuen wir uns, Ihnen eine CME Fortbildung zur Präeklampsie kostenlos zur Verfügung stellen zu können.


Sie finden Sie unter folgendem Öffnet externen Link im aktuellen FensterLink.

Publikationen der letzten fünf Jahre

Verlohren S, Melchiorre K, Khalil A, Thilaganathan B. Uterine artery Doppler, birthweight and timing of preeclampsia onset: providing insights into the dual etiology of late-onset preeclampsia. Ultrasound Obstet Gynecol. 2014 Jan 21. doi: 10.1002/uog.13310. [Epub ahead of print]

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F Galindo A, Schoofs K, Denk B, Stepan H. New gestational phase specific cut-off values for the use of the sFlt-1/PlGF-ratio as a diagnostic test for preeclampsia. Hypertension 2014; 63(2):346-52.

Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W, Verlohren S. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. Journal of Perinatal Medicine 2014; 42(1):61-8.

Kolisek M, Galaviz-Hernández C, Vázquez-Alaniz F, Sponder G, Javaid S, Kurth K, Nestler A, Rodríguez-Moran M, Verlohren S, Guerrero-Romero F, Aschenbach JR, Vormann J. SLC41A1 is the only magnesium responsive gene significantly overexpressed in placentas of preeclamptic women. Hypertens Pregnancy 2013; 32(4):378-89.

Engels T, Pape J, Schoofs K, Henrich W, Verlohren S. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertension in Pregnancy 2013; 32(4):459-73.

Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 2013; 32(2):189-201.

Cornelis T, Spaanderman M, Beerenhout C, Perschel FH, Verlohren S, Schalkwijk CG, van der Sande FM, Kooman JP, Hladunewich M. Antiangiogenic factors and maternal hemodynamics during intensive hemodialysis in pregnancy. Hemodial Int 2013; Oct;17(4):639-43.

Herse F, Lamarca B, Hubel CA, Kaartokallio T, Lokki AI, Ekholm E, Laivuori H, Gauster M, Huppertz B, Sugulle M, Ryan MJ, Novotny S, Brewer J, Park JK, Kacik M, Hoyer J, Verlohren S, Wallukat G, Rothe M, Luft FC, Muller DN, Schunck WH, Staff AC, Dechend R. Cytochrome P450 Subfamily 2J Polypeptide 2 Expression and Circulating Epoxyeicosatrienoic Metabolites in Preeclampsia. Circulation 2012; 126(25):2990-9.

Rana S, Hacker MR, Merport A, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension 2012; 60(2):451-8.

Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA.  Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia. Circulation 2012, 25(7):911-9.

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012, 206(58):e51-58.

Verlohren S, Stepan H, Dechend R: Angiogenic growth factors in the diagnosis and prediction of preeclampsia. Clin Sci 2012, 122:43-52.

Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J.  [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]. Z Geburtshilfe Neonatol 2010 Dec, 214(6):234-8.

Verlohren S, Geusens N, Morton J, Verhaegen I, Hering L, Herse F, Dudenhausen JW, Muller DN, Luft FC, Cartwright JE, Davidge ST, Pijnenborg R, Dechend, R: Inhibition of Trophoblast-Induced Spiral Artery Remodeling Reduces Placental Perfusion in Rat Pregnancy. Hypertension 2010, 56:304-1.

Hering L, Herse F, Geusens N, Verlohren S, Wenzel K, Staff AC, Brosnihan KB, Huppertz B, Luft FC, Mueller DN, Pijnenborg R, Cartwright JE, Dechend, R.: Effects of Circulating and Local Uteroplacental Angiotensin II in Rat Pregnancy. Hypertension 2010, 56:311-8.

Geusens N, Hering L, Verlohren S, Luyten C, Drijkoningen K, Taube M, Vercruysse L, Hanssens M, Dechend R, Pijnenborg R: Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model. Placenta 2010, 31:320-326.

Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H: An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010, 202:161e1-11.

Verlohren S, Muller DN, Luft FC, Dechend R: Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension. 2009, 54:439-443.

Tintu A*, Rouwet E*, Verlohren S*, Brinkmann J, Ahmad S, Crispi F, van Bilsen M, Carmeliet P, Staff AC, Cetin I, Gratacos E, Hernandez-Andrade E, Hofstra L, Jacobs M, Lamers W, Morano I, Narula J, Safak E, Ahmed A, le Noble F: Hypoxia Induces Dilated Cardiomyopathy in the Chick Embryo; Mechanism, Intervention, and Long-term Consequences. PLoS ONE 2009, 4:e5155.

Herse F*, Verlohren S*, Wenzel K*, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, Redman CW, Dechend R: Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009, 53:393-398.

Forschungsdatenbank

Für mehr Details nutzen Sie bitte auch die undefinedForschungsdatenbank der Charité.